Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Glioblastoma 8 Brain Neoplasms 4 Neoplasms 1 Glioma 1 Drug Resistant Epilepsy 1 Autism Spectrum Disorder 1

Interventions

Temozolomide 19 Bevacizumab 14 Irinotecan 12 Carboplatin 10 Cyclophosphamide 9 Radiosurgery 8 Lomustine 8 Radiotherapy 7 pembrolizumab 6 Vincristine 6 Topotecan 6 Drug Therapy 6 Surgical Procedures, Operative 5 Etoposide 5 Doxorubicin 5 Cisplatin 5 3-Iodobenzylguanidine 5 trametinib 4 Metformin 4 Gemcitabine 4 Dexamethasone 4 Blood Specimen Collection 4 poly ICLC 3 dabrafenib 3 Vorinostat 3 Trastuzumab 3 Therapeutics 3 Radiation 3 Paclitaxel 3 Observation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Diet, Ketogenic × CNS × Clear all

NCT01865162 2022-11-09

KGDinGBM

Mid-Atlantic Epilepsy and Sleep Center, LLC

Phase 1 Completed

Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡